Average Co-Inventor Count = 11.29
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (27 from 1,970 patents)
2. Bristol-myers Squibb Compnay (10 from 3,681 patents)
3. Viiv Healthcare UK Limited (9 patents)
37 patents:
1. 12459932 - KIF18A inhibitors
2. 12441736 - KIF18A inhibitors
3. 12440491 - KRAS G12C inhibitors and methods of using the same
4. 12435058 - KIF18A inhibitors
5. 12083121 - Substituted piperazines as KRAS G12C inhibitors
6. 11766436 - KRAS G12C inhibitors and methods of using the same
7. 11285156 - Substituted piperazines as KRAS G12C inhibitors
8. 11090304 - KRAS G12C inhibitors and methods of using the same
9. 9777019 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
10. 9611261 - Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
11. 9556135 - Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
12. 9550762 - Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
13. 9296698 - Amino heteroaryl compounds as beta-secretase modulators and methods of use
14. 9296759 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
15. 9296734 - Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use